Table of Contents Table of Contents
Previous Page  216 / 413 Next Page
Information
Show Menu
Previous Page 216 / 413 Next Page
Page Background

18

2008 vol. 1

Pharmaceutical

Reversed phase HPLC analyses are predominantly performed on C18

columns, which, in many cases, are suitable. There are, however, situations in

which a conventional C18 column produces less than optimal chromatogra-

phy. For example, C18 columns have little retention for hydrophilic com-

pounds, basic compounds often exhibit peak tailing, and highly aqueous con-

ditions can cause inconsistent retention or even phase collapse.

One way in which column manufacturers attempt to address these issues, and

yet maintain the favorable hydrophobic interaction of a C18 column, is to

impart polar functionality into an alkyl phase. The Ultra IBD column is an

example of such a polar embedded column. Compared to a C18 column, this

column offers enhanced retention and selectivity towards a wider range of

compounds, orthogonal separations, improved base-deactivation, and com-

patibility with entirely aqueous mobile phases.

Degree of Polarity

The Ultra IBD column exhibits a high degree of polarity relative to conven-

tional and aqueous C18 phases. Because the Ultra IBD column possesses both

nonpolar and highly polar characteristics, it can be used in both normal phase

mode and reversed phase mode. The bonding chemistry used in the Ultra IBD

column makes it a very adaptable column capable of unique separations.

Base-Deactivation

The Ultra IBD column bonding chemistry alleviates one of the common

problems associated with alkyl phases—peak tailing of basic analytes.

Comparing the analysis of amitriptyline on a conventional C18 column and

an Ultra IBD column demonstrates the effectiveness of this bonding chem-

istry. Amitriptyline is a highly basic, tricyclic antidepressant that commonly

tails on silica-based alkyl phases. Even at a neutral pH and, importantly, with

no modifiers, the Ultra IBD column exhibits excellent peak shape for

amitriptyline (Figure 1). This is advantageous because it provides needed flex-

ibility for method development, especially for analytes that are labile under

acidic conditions. In applications where Gaussian peak shape is needed for

accurate integrations, such as potency assays, or when tighter system suitabil-

ity criteria are required, an intrinsically base-deactivated stationary phase

offers a benefit that a conventional C18 column cannot—exceptional peak

shape with a simplified mobile phase.

Retention and Selectivity

In contrast to conventional C18 columns, the Ultra IBD has a polar functional

group embedded within the alkyl chain. Retention, therefore, is attributed not

only to hydrophobic interactions (the major retention mechanism of an alkyl

(or C18) phase, but also to polar attraction between the analyte and stationary

phase. This mixed-mode mechanism results in high retention for hydrophilic

compounds or compounds with polar moieties, such as purines (Figure 2).

Orthogonal separations also can be achieved through the Ultra IBD phase

chemistry. For example, a small group of hydroxybenzoic acids was also assayed

on a C18 and IBD column under identical conditions. The elution order of the

analytes differed and dihydroxybenzoic acid was more retained on the Ultra

IBD column (Figure 3). Additionally, the unique phase chemistry of the Ultra

IBD column makes it suitable for a simultaneous analysis of a wide range of

compounds—acidic through basic, as well as zwitterions (Figure 4).

Multi-task with an Ultra IBD Column

A Versatile Column with Many Applications

By Rick Lake, Pharmaceutical Innovations Chemist

• Effective in normal or reversed mode; compatible with 100% aqueous mobile phases.

• Excellent base deactivation—superior peak shape for basic compounds.

• Enhanced retention of hydrophilic compounds.

Figure 1

Ultra IBD offers more flexibility in

method development giving excellent

peak shape for highly basic compounds—

even without mobile phase modifiers—

over a wide mobile phase pH range.

Sample:

Inj.:

10µL

Conc.:

~100µg/mL

Sample diluent: mobile phase

Column:

Ultra IBD

Cat.#:

9175565

Dimensions: 150mm x 4.6mm

Particle size: 5µm

Pore size:

100Å

Conditions:

Mobile phase: 10:90 20mM

potassium phosphate

(pH 3):methanol

Flow:

1.0mL/min.

Temp.:

ambient

Det.:

UV @ 254nm

Peak List

1. amitriptyline

LC_PH0443

Mobile Phase pH 3

USP tailing 1.10

Mobile Phase pH 7

USP tailing 1.13

LC_PH0444